TY  - CONF

T1  - Growth Analysis at Baseline in Children and Adolescents with Moderate-to-Severe Atopic Dermatitis Enrolled in Phase 3 Dupilumab Trials

JO  - JOURNAL OF INVESTIGATIVE DERMATOLOGY

PY  - 2025/03/01

AU  - Irvine A

AU  - Paller AS

AU  - Siegfried EC

AU  - Cork MJ

AU  - Beck LA

AU  - Chen Z

AU  - Peralta C

AU  - Zhang A

AU  - Levy S

AU  - Cyr SL

ED  - 

VL  - 145

IS  - 3

SP  - e26

EP  - e26

Y2  - 2025/10/26

ER  -